Skip to main content
SpringerLink
Log in

Alemtuzumab

Autoimmune haemolytic anaemia and relapse of multiple sclerosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tzartos J, et al. Concurrent autoimmune hemolytic anemia and multiple sclerosis relapse in the presence of aquaporin-1 antibodies, following treatment with Alemtuzumab. Multiple Sclerosis Journal 25 (Suppl. 2): 867 (plus poster) abstr. EP1562, 2019. Available from: URL: http://doi.org/10.1177/1352458519872904 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1802, 19 (2020). https://doi.org/10.1007/s40278-020-77937-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-77937-9

Search

Navigation